Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Differential Outcomes with Empagliflozin and Dapagliflozin in Heart Failure with Mildly Reduced Ejection Fraction.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Differential Outcomes With Empagliflozin and Dapagliflozin in Heart Failure With Mildly Reduced Ejection Fraction With and Without Diabetes Mellitus.
Journal: The American journal of cardiology
Published: January 23, 2026
Differential Outcomes With Empagliflozin and Dapagliflozin in Heart Failure With Mildly Reduced Ejection Fraction With and Without Diabetes Mellitus.
Journal: The American journal of cardiology
Published: January 23, 2026
Additive Cardiorenal Benefits of Finerenone and SGLT2 Inhibitor Combination Therapy in Diabetic CKD: A Propensity-Matched Real-World Study.
Journal: The American journal of cardiology
Published: January 01, 2026
Showing 1-4 of 4
Last Updated: 09/26/2026